Skip to main content
BKD logo

BKD · Brookdale Senior Living Inc.

Track BKD — free
$12.64 +0.09 (+0.72%) At close · Aug 14
Market Cap
$3.02B
Shares
238.82M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$12.64 Open$12.51 Day$12.46–12.82 52W close$7.19–16.77 Avg vol 30d5.5M Short int38.7M · 16.2% float · 7.9d Short vol48% Last earningsAug 10, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 10

Up next

Next earnings call
Nov 12, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 10, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Sell Momentum Weak Sentiment Neutral Fundamentals Fair Quant / Vol High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −4%
      below
      Price vs 50-day avg −12%
      below
      RSI (14) 33
      neutral
      MACD trend Negative
      52-week position 57%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Weak
      1-month return −16%
      trailing
      6-month return −18%
      trailing
      YTD return +17%
      this year
      Relative strength −32%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $14 › 200d $13 — 50d above 200d
      Institutional flow Accumulating
      +2% holders QoQ · +51 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      16.20% of float · ▲ +3.1% MoM · 7.9 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      289 holders — near 3-yr high, broad support
      Squeeze score 71
      high risk · 0–100
      Fundamentals
      Fair
      Revenue growth −5%
      Y/Y
      Gross margin 18%
      expanding
      EPS growth −26%
      Y/Y
      Free cash flow $16.5M
      Buyback $44.0M
      remaining
      Balance sheet $4.0B
      net debt
      Quant / Vol
      risk profile
      High
      Volatility 40%
      annualized · 1-yr
      Max drawdown −29%
      past year
      ATR 5.3%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Aug 10, 2026
      RevPAR year-over-year growth · Full Year 2026 Maintained 8% – 9%
      Jan 28, 2026 8% – 9% changed to Aug 10, 2026 8% – 9%
      Adjusted EBITDA · Full Year 2026 Non-GAAP Maintained $502M – $516M
      Jan 28, 2026 $502M – $516M changed to Aug 10, 2026 $502M – $516M
      Prior guidance period ended · from the 8-K filed Nov 6, 2025
      Adjusted EBITDA · full year 2025 $455M – $460M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Sell
      2 · 5 · 0
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −4% Neutral
      Price vs 50-day avg
      −12% Bearish
      RSI (14)
      33 Neutral
      MACD trend
      Negative Bearish
      52-week position
      57% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $14 › 200d $13 — 50d above 200d
      Institutional flow Accumulating
      +2% holders QoQ · +51 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      16.20% of float · ▲ +3.1% MoM · 7.9 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      289 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $7 Now $13 · 57% Range high $17
      vs 200-day avg -4% vs 50-day avg -12%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted Net Debt non-GAAP $5.07B as of June 30, 2026
      Net Debt as of June 30, 2026 non-GAAP $3.9B as of June 30, 2026
      Number of communities 541 as of June 30, 2026
      Number of states 41 as of June 30, 2026
      Operating and financing lease obligations as of June 30, 2026 $1.17B as of June 30, 2026
      residents served (capacity) 46,000 as of June 30, 2026
      Total Liquidity $566M 06/30/2026
      June weighted average occupancy 82.5% June 2026
      Second quarter weighted average occupancy 82.4% 2Q 2026
      Total average units 43,637 1Q 2026
      consolidated month end occupancy 83.3% March 2026
      Adjusted Free Cash Flow non-GAAP 22.82M FY2025
      RevPOR $6,347 FY2025
      Weighted average occupancy 80.9% FY2025
      RevPAR year-over-year growth 5.7% the year ended December 31, 2025
      Same Community month-end occupancy 84.3% December 2025

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Care Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      BKD
      Brookdale Senior Living Inc.
      this stock
      $3.02B +17.1% -4.5% 16.2%
      HCA
      HCA Healthcare, Inc.
      $89.77B -13.3% +7.1% 13.9 2.7%
      FSNUY
      Fresenius SE & Co. KGaA
      $30.87B -4.4% 0.0%
      THC
      Tenet Healthcare Corp
      $21.57B +34.8% +0.9% 10.3 4.0%
      FMS
      Fresenius Medical Care AG
      $12.65B -0.2% +5.9% 0.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      289
      % held
      114.3%
      Net QoQ
      +15.7M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      235
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      38.7M
      Days to cover
      7.9d
      Change
      +1.2M sh
      View
      Short Volume
      Short vol %
      48%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      905
      Value
      $13.0K
      As of
      Jul 13, 2026
      View
      Off-Exchange
      Off-exchange %
      39.0%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $3.2B
      Net income (FY)
      $-262.7M
      EPS diluted
      $-1.12
      View
      Buybacks
      Authorized
      $100.0M
      Remaining
      $44.0M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 10, 2026
      This year
      13
      View
      Proposed Sales
      Value
      $207.8K
      Shares
      20.0K
      Filed
      Nov 12, 2025
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 10, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      BKD -11.1% -15.8% -18.1% -13.4% +17.2%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY -11.5% -20.2% -31.9% -17.3% +3.3%

      Capital returns

      Buyback program · as of Mar 31, 2026
      Authorized
      $100.00M
      Spent (derived)
      $56.00M
      Remaining
      $44.00M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1332349 CUSIP 112463104 13F (30d) 283 filings 276 filers Visit website